Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Synta Announces Positive One-Year Follow-up Results for the GALAXY-1 Trial of Ganetespib in NSCLC at the 2013 World Conference on Lung Cancer
Yahoo/BusinessWire
Saturday, October 26, 2013 - 11:12am
tags:
ganetespib, lung cancer, Synta Pharmaceuticals, adenocarcinoma
Immunogen Inc's CEO Discusses Q1 2014 Results - Earnings Call Transcript
Seeking Alpha
Saturday, October 26, 2013 - 10:57am
tags:
Immunogen, earnings
What Shutdown? Illumina Rises Above The Noise
Seeking Alpha
Saturday, October 26, 2013 - 10:51am
tags:
Illumina
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
investors.com
Saturday, October 26, 2013 - 10:49am
tags:
Biogen Idec, MS, multiple sclerosis
Provenge Drug Maker Dendreon Said to Be Seeking Takeover Offers
Bloomberg
Saturday, October 26, 2013 - 8:08am
tags:
Dendreon, M&A, Provenge
FDA panel backs Gilead Sciences' hepatitis C drug
Yahoo/AP
Saturday, October 26, 2013 - 8:07am
tags:
Gilead, FDA, advisory panels, hepatitis C, sofosbuvir
Q3 Earnings Roundup for Pharmaceutical Stocks
InvestorPlace
Friday, October 25, 2013 - 11:37am
tags:
earnings, Amgen, Eli Lilly, Bristol-Myers Squibb
Can a change of scenery revive AstraZeneca's stilted R&D?
Fierce Biotech
Friday, October 25, 2013 - 11:33am
tags:
R&D, AstraZeneca
Can Merck's Breadth Beat AbbVie's and Pfizer's Focus?
Motley Fool
Friday, October 25, 2013 - 11:32am
tags:
Merck, Pfizer, AbbVie
Will This Pharmaceutical Company Keep Hitting All-Time Highs?
Motley Fool
Friday, October 25, 2013 - 11:30am
tags:
Shire
Allergan (AGN) Earnings Projected to Increase
Forbes
Friday, October 25, 2013 - 10:19am
tags:
Allergan, earnings
[video]2 Big Pharma Giants Headed in Opposite Directions
Motley Fool
Friday, October 25, 2013 - 10:18am
tags:
GSK, Bristol-Myers Squibb
Earnings Expected to Increase for Pfizer (PFE)
Forbes
Friday, October 25, 2013 - 10:17am
tags:
Pfizer, earnings
Abbott says FDA approved heart valve medical device
Reuters
Friday, October 25, 2013 - 10:05am
tags:
Abbott Labs, devices, FDA, MitraClip
U.S. Recommends Tighter Control on Hydrocodone Pain Pills
Bloomberg
Friday, October 25, 2013 - 10:04am
tags:
hydrocodone, Zohydro, Zogenix, FDA
Partnerships Have Been a Boost for Inovio
Motley Fool
Friday, October 25, 2013 - 9:59am
tags:
Inovio, Roche
BioMarin Pharma Q3 Net Loss Deepens, Revenue Rises
Motley Fool
Friday, October 25, 2013 - 9:58am
tags:
earnings, Biomarin
Pfizer Leads Jump in Pharmaceutical Lobbying
Roll Call
Friday, October 25, 2013 - 9:57am
tags:
lobbying, Pfizer
Eisai Loses Lawsuit Against DEA Over Scheduling Epilepsy Pill
Pharmalot
Friday, October 25, 2013 - 9:55am
tags:
Eisai, DEA, epilepsy, Fycompa
Novartis' Pharmaceutical Business Faces 2 Major Challenges
Motley Fool
Friday, October 25, 2013 - 9:41am
tags:
Novartis, Gilenya, Tecfidera, GSK, Seebri Breezhaler, COPD, Xolair

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.